Pharmaceutical Company Reviews Data Security Policies to Comply With U.S. and EU Law

North America - United States | Europe

A Fortune 200 pharmaceutical company retained our firm to oversee the 2013 review of the company’s data security policies and procedures related to new healthcare data reporting services. Our professionals worked to ensure compliance under applicable U.S. and EU statutes and regulations.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.